Literature DB >> 12371799

The newer antimuscarinic drugs: bladder control with less dry mouth.

Rodney A Appell1.   

Abstract

Two newer antimuscarinic anticholinergic drugs--tolterodine and extended-release oxybutynin--are approximately as effective in treating overactive bladder as immediate-release oxybutynin, but are more tolerable. I review clinical trial data on the newer agents.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12371799     DOI： 10.3949/ccjm.69.10.761

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  6 in total

Review 1.  Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.

Authors:  Denis Getsios; Wissam El-Hadi; Ingrid Caro; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 2.  Lesions in the oral cavity and esophagus caused by prescribed drugs: A review.

Authors:  Snezana Tesic-Rajkovic; Biljana Radovanovic-Dinic
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-11-05       Impact factor: 1.245

3.  Efficacy and tolerability of combined medication of two different antimuscarinics for treatment of adults with idiopathic overactive bladder in whom a single agent antimuscarinic therapy failed.

Authors:  Junseok Yi; Seong Jin Jeong; Min Soo Chung; Hongzoo Park; Sang Wook Lee; Seung Hwan Doo; Cheol Yong Yoon; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

4.  Oxybutynin extended release and tolterodine immediate release : a health economic comparison.

Authors:  D Getsios; J J Caro; K J Ishak; W El-Hadi; K Payne; M O'connel; D Albrecht; W Feng; D Dubois
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 5.  Social, economic, and health utility considerations in the treatment of overactive bladder.

Authors:  Emilio Sacco; Daniele Tienforti; Alessandro D'Addessi; Francesco Pinto; Marco Racioppi; Angelo Totaro; Daniele D'Agostino; Francesco Marangi; Pierfrancesco Bassi
Journal:  Open Access J Urol       Date:  2010-02-11

6.  Adherence to Anticholinergic Therapy and Clean Intermittent Self-Catheterization in Patients With Multiple Sclerosis.

Authors:  Damien Motavasseli; Camille Chesnel; Audrey Charlanes; Diane Menoux; Francis Charoenwong; Frédérique Le Breton; Gérard Amarenco
Journal:  Int Neurourol J       Date:  2018-06-30       Impact factor: 2.835
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.